Getinge acquires Talis Clinical LLC, a leading innovator of High Acuity cloud-based software solutions

Rhea-AI Summary

Getinge has acquired Talis Clinical LLC, a US-based provider of high acuity cloud-based software solutions, for SEK 596 M. The acquisition aims to enhance patient care documentation throughout critical care processes. Talis Clinical offers advanced applications built on the ACG-Engine™, which integrates with medical devices and patient data management systems. With a global market potential exceeding SEK 50 B, and expected net sales of SEK 40 M in 2021, this acquisition aligns with Getinge's digital strategy to improve patient outcomes and reduce treatment costs.

Positive

• Acquisition enhances Getinge's digital strategy and integrates advanced software solutions.
• Positioning in a global market valued at over SEK 50 B, with significant US presence.
• Potential for synergy between Talis Clinical and Getinge's existing services.

Negative

• None.

GOTHENBURG, Sweden, Dec. 23, 2021 /PRNewswire/ -- Getinge announces the acquisition of 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based software solutions. Talis Clinical's offer is designed to support and document care throughout the general and cardiac perioperative care process, but also through labor and delivery episodes and critical care support including ECMO Therapy.

"Connecting life-saving medical devices with other data sources and presenting the right data to the right clinician is instrumental in supporting better patient outcomes and lower treatment costs", says Jens Viebke, President Acute Care Therapies at Getinge. "Talis Clinical enables this by combining state-of-the-art technology with a deep understanding of the real needs in high acquity settings, and will be a key cornerstone in Getinge's digital strategy moving forward." 

Talis Clinical was founded in 2013 to support patient care and positively impact clinicians and healthcare organizations. The company's suite of applications is built on a highly innovative and sophisticated platform called Advanced Clinical Guidance (ACG-Engine™). The ACG-Engine comes with interfaces to a wide range of Point Of Care Devices as well as Patient Data Management Systems and includes high value functions that facilitate oversight and process improvements.  

The addressable global market is estimated to be more than SEK 50 B, of which half only is in the US. Talis Clinical currently employs 57 persons and the net sales for 2021 is estimated to SEK 40 M. The company has its headquarter in Streetsboro, Ohio, US and will be reported as a part of the business area Acute Care Therapies.

"We are delighted to become part of Getinge", says Gary Colister, President and Founder of Talis Clinical. "We see incredible synergy in our missions and a tremendous opportunity to patients by working together.  Now more than ever, clinicians working in high acuity care areas need scalable solutions that empower and engage them. Getinge will help us reach more clinicians and patients faster than we could have alone."

At the time of the acquisition, Getinge has paid SEK 596 M for 100% of the equity interest in Talis Clinical LLC on a debt-free basis and subject to customary working capital adjustments. In addition, additional earn-outs may be paid up until 2026 to the extent that the agreed milestone for each earn-out is reached.

Getinge does not expect any material integration costs and the acquisition is not expected to have a material impact on Getinge's earnings in the near term. The purchase price is financed with available cash previously raised in the Swedish Debt Capital Market.

For more information about Talis Clinical LLC: www.talisclinical.com

Media contact:

Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
Email: anna.appelqvist@getinge.com 

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/getinge/r/getinge-acquires-talis-clinical-llc--a-leading-innovator-of-high-acuity-cloud-based-software-solutio,c3478079

The following files are available for download:

https://mb.cision.com/Main/942/3478079/1514436.pdf	Getinge acquires Talis Clinical LLC
https://news.cision.com/getinge/i/getinge---jens-viebke,c2995981	Getinge - Jens Viebke

View original content:https://www.prnewswire.com/news-releases/getinge-acquires-talis-clinical-llc-a-leading-innovator-of-high-acuity-cloud-based-software-solutions-301450477.html

SOURCE Getinge

FAQ

What is the purpose of Getinge's acquisition of Talis Clinical LLC?

Getinge aims to enhance patient care documentation and improve outcomes through Talis Clinical's advanced software solutions.

What is the financial value of the acquisition of Talis Clinical by Getinge?

The acquisition was made for SEK 596 M on a debt-free basis.

How does Talis Clinical's software impact healthcare delivery?

Talis Clinical's software connects medical devices and data sources, supporting better patient outcomes and lower treatment costs.

What are the expected financial implications of the acquisition for Getinge?

Getinge does not anticipate any material integration costs or significant short-term impacts on earnings.

How much revenue does Talis Clinical project for 2021?

Talis Clinical estimates its net sales for 2021 to be SEK 40 M.